leads the way in the discovery and production of saponin-based adjuvants. Its flagship product, STIMULON™ QS-21, is a cornerstone of adjuvant systems in multiple licensed vaccines, addressing ...

January 30, 2025--(BUSINESS WIRE)--SaponiQx, a leader in next-generation saponin-based adjuvant discovery ... s innovative cultured plant cell QS-21 (cpcQS-21) adjuvant technology, which delivers ...

Cell Culture Technology Enables Sustainable, High-Performance Vaccine Adjuvant Production for Global Health Needs SaponiQx, a leader in next-generation saponin ... plant cell QS-21 (cpcQS-21 ...

About Q-Vant Biosciences Q-Vant is a privately held biosciences company that has solved the supply chain problem of QS-21 and other Quillaja-based saponin adjuvants for the global human and animal ...